Global Defibrillators Market – Industry analysis and forecast (2019-2027) by product, end user and region.

Global Defibrillators Market is expected to reach US$ XX Bn by 2027 at a CAGR of 5.5 % during the forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. To Know About The Research Methodology :- Request Free Sample Report

Global Defibrillators Market overview:

The defibrillator is an electrical device that supplies a dose of electric current to the heart, this depolarizes a critical mass of the heart muscle, terminates the dysrhythmia, and allows normal sinus rhythm to be re-established by the body’s natural pacemaker. These devices play a crucial role when a patient is experiencing a cardiac emergency and has no pulse. These devices are widely used in hospitals, clinics, & cardiac centers, and pre-hospital. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. Rising incidences of cardiac diseases, rapid growth in the aging population, technological advancements in defibrillators, and increasing awareness about public-access defibrillators, would create commercial market opportunities. Defibrillators market is growing at a very fast pace because of rising cardiovascular diseases, this is one of the most important factors in the growth of the market. However, the preference of drugs over defibrillators, strict FDA regulations and low awareness regarding defibrillators in the underdeveloped market are the major hindrances of the defibrillator's market growth. On the other hand, the development of new MRI labelled devices and growing healthcare expenditure in the APAC region may act as an opportunity in the growth of the market.

Global Defibrillators Market Segment Analysis:

According to the product, the Implantable Cardioverter Defibrillators (ICDs) segment is expected to be the fastest-growing segment on account of increasing health consciousness and the adoption of advanced technology. Among the end-user segment, hospitals, clinics, and cardiac centers are considered attractive market segment and are expected to hold a significant share of the market in the coming years along with growth can be attributed to factors such as rising adoption of technology advancement.

Global Defibrillators Market Regional Analysis:

Regions-wise, the North America region is expected to grow at the highest CAGR of XX% during the forecast period thanks to an increased incidence of cardiovascular diseases, supportive government policies, favourable reimbursement schemes, increasing awareness, and an increase in training programs. Also, the APAC region is expected to grow at the highest CAGR of XX% during the forecast period thanks to increasing awareness and accessibility of these devices. In addition, the increasing prevalence of cardiovascular diseases in this region also supports the growth of this segment. In the defibrillators market, Medtronic leads the market position thanks to production capacity growth, brand portfolio expansion, mergers, collaborations, and acquisitions. Over the past three years, the company has adopted new product launches, product enhancements, and geographic expansion as its crucial business plans to certify its dominance in the defibrillators market. The objective of the report is to present a comprehensive analysis of the Global Defibrillators Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by Region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by Region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Defibrillators Market dynamics, structure by analyzing the market segments and project the Global Defibrillators Market size. Clear representation of competitive analysis of key players by Type, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Defibrillators Market make the report investor’s guide.

The Scope of the Global Defibrillators Market: Inquire before buying

Global Defibrillators Market, by Product

• Implantable Cardioverter Defibrillators (ICDs) • Transvenous Implantable Cardioverter Defibrillators (T-ICDs) • Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) • Dual-chamber ICDs • Single-chamber ICDs • Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) • External Defibrillators • Automated External Defibrillators (AEDs) • Semi-automated External Defibrillators • Fully Automated External Defibrillators • Manual External Defibrillators • Wearable Cardioverter Defibrillators (WCDs)

Global Defibrillators Market, by End User

• Hospitals, Clinics, and Cardiac Centers • Pre-Hospital Care Settings • Public Access Markets • Home Care Settings • Alternate Care Facilities

Global Defibrillators Market, by Region

• North America • Europe • APAC • Latin America • MEA

Global Defibrillators Market Key Players

• Medtronic • St. Jude Medical • Boston Scientific • Philips • ZOLL Medical Corporation • BIOTRONIK • Cardiac Science Corporation • ZOLL Medical Corporation • Medtronic PLC • LivaNova PLC • Physio-Control, Inc. • Nihon Kohden Corporation. • Abbott • Physio-Control, Inc. • Koninklijke Philips N.V. • Nihon Kohden Corporation • Microport • CU Medical System Inc •Stryker •Asahi Kasei Corporation

Defibrillators Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Defibrillators Market, By Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Defibrillators Market Analysis and Forecast 6.1. Global Defibrillators Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Defibrillators Market Analysis and Forecast, By End User 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Defibrillators Market Value Share Analysis, By End User 7.4. Global Defibrillators Market Size (US$ Bn) Forecast, By End User 7.5. Global Defibrillators Market Analysis, By End User 7.6. Global Defibrillators Market Attractiveness Analysis, By End User 8. Global Defibrillators Market Analysis and Forecast, By Product 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Defibrillators Market Value Share Analysis, By Product 8.4. Global Defibrillators Market Size (US$ Bn) Forecast, By Product 8.5. Global Defibrillators Market Analysis, By Product 8.6. Global Defibrillators Market Attractiveness Analysis, By Product 9. Global Defibrillators Market Analysis, By Region 9.1. Global Defibrillators Market Value Share Analysis, By Region 9.2. Global Defibrillators Market Size (US$ Bn) Forecast, By Region 9.3. Global Defibrillators Market Attractiveness Analysis, By Region 10. North America Defibrillators Market Analysis 10.1. Key Findings 10.2. North America Defibrillators Market Overview 10.3. North America Defibrillators Market Value Share Analysis, By End User 10.4. North America Defibrillators Market Forecast, By End User 10.4.1. Hospitals, Clinics, and Cardiac Centers 10.4.2. Pre-Hospital Care Settings 10.4.3. Public Access Markets 10.4.4. Home Care Settings 10.4.5. Alternate Care Facilities 10.5. North America Defibrillators Market Value Share Analysis, By Product 10.6. North America Defibrillators Market Forecast, By Product 10.6.1. Implantable Cardioverter Defibrillators (ICDs) 10.6.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 10.6.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 10.6.1.1.2. Dual-chamber ICDs 10.6.1.1.3. Single-chamber ICDs 10.6.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 10.6.2. External Defibrillators 10.6.2.1. Automated External Defibrillators (AEDs) 10.6.2.1.1. Semi-automated External Defibrillators 10.6.2.1.2. Fully Automated External Defibrillators 10.6.2.2. Manual External Defibrillators 10.6.2.3. Wearable Cardioverter Defibrillators (WCDs) 10.7. North America Defibrillators Market Value Share Analysis, By Country 10.8. North America Defibrillators Market Forecast, By Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Defibrillators Market Analysis, By Country 10.10. U.S. Defibrillators Market Forecast, By End User 10.10.1. Hospitals, Clinics, and Cardiac Centers 10.10.2. Pre-Hospital Care Settings 10.10.3. Public Access Markets 10.10.4. Home Care Settings 10.10.5. Alternate Care Facilities 10.11. U.S. Defibrillators Market Forecast, By Product 10.11.1. Implantable Cardioverter Defibrillators (ICDs) 10.11.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 10.11.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 10.11.1.1.2. Dual-chamber ICDs 10.11.1.1.3. Single-chamber ICDs 10.11.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 10.11.2. External Defibrillators 10.11.2.1. Automated External Defibrillators (AEDs) 10.11.2.1.1. Semi-automated External Defibrillators 10.11.2.1.2. Fully Automated External Defibrillators 10.11.2.2. Manual External Defibrillators 10.11.2.3. Wearable Cardioverter Defibrillators (WCDs) 10.12. Canada Defibrillators Market Forecast, By End User 10.12.1. Hospitals, Clinics, and Cardiac Centers 10.12.2. Pre-Hospital Care Settings 10.12.3. Public Access Markets 10.12.4. Home Care Settings 10.12.5. Alternate Care Facilities 10.13. Canada Defibrillators Market Forecast, By Product 10.13.1. Implantable Cardioverter Defibrillators (ICDs) 10.13.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 10.13.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 10.13.1.1.2. Dual-chamber ICDs 10.13.1.1.3. Single-chamber ICDs 10.13.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 10.13.2. External Defibrillators 10.13.2.1. Automated External Defibrillators (AEDs) 10.13.2.1.1. Semi-automated External Defibrillators 10.13.2.1.2. Fully Automated External Defibrillators 10.13.2.2. Manual External Defibrillators 10.13.2.3. Wearable Cardioverter Defibrillators (WCDs) 10.14. North America Defibrillators Market Attractiveness Analysis 10.14.1. By End User 10.14.2. By Product 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Development 11. Europe Defibrillators Market Analysis 11.1. Key Findings 11.2. Europe Defibrillators Market Overview 11.3. Europe Defibrillators Market Value Share Analysis, By End User 11.4. Europe Defibrillators Market Forecast, By End User 11.4.1. Hospitals, Clinics, and Cardiac Centers 11.4.2. Pre-Hospital Care Settings 11.4.3. Public Access Markets 11.4.4. Home Care Settings 11.4.5. Alternate Care Facilities 11.5. Europe Defibrillators Market Value Share Analysis, By Product 11.6. Europe Defibrillators Market Forecast, By Product 11.6.1. Implantable Cardioverter Defibrillators (ICDs) 11.6.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 11.6.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 11.6.1.1.2. Dual-chamber ICDs 11.6.1.1.3. Single-chamber ICDs 11.6.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 11.6.2. External Defibrillators 11.6.2.1. Automated External Defibrillators (AEDs) 11.6.2.1.1. Semi-automated External Defibrillators 11.6.2.1.2. Fully Automated External Defibrillators 11.6.2.2. Manual External Defibrillators 11.6.2.3. Wearable Cardioverter Defibrillators (WCDs) 11.7. Europe Defibrillators Market Value Share Analysis, By Country 11.8. Europe Defibrillators Market Forecast, By Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Defibrillators Market Analysis, By Country 11.10. Germany Defibrillators Market Forecast, By End User 11.10.1. Hospitals, Clinics, and Cardiac Centers 11.10.2. Pre-Hospital Care Settings 11.10.3. Public Access Markets 11.10.4. Home Care Settings 11.10.5. Alternate Care Facilities 11.11. Germany Defibrillators Market Forecast, By Product 11.11.1. Implantable Cardioverter Defibrillators (ICDs) 11.11.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 11.11.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 11.11.1.1.2. Dual-chamber ICDs 11.11.1.1.3. Single-chamber ICDs 11.11.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 11.11.2. External Defibrillators 11.11.2.1. Automated External Defibrillators (AEDs) 11.11.2.1.1. Semi-automated External Defibrillators 11.11.2.1.2. Fully Automated External Defibrillators 11.11.2.2. Manual External Defibrillators 11.11.2.3. Wearable Cardioverter Defibrillators (WCDs) 11.12. U.K. Defibrillators Market Forecast, By End User 11.12.1. Hospitals, Clinics, and Cardiac Centers 11.12.2. Pre-Hospital Care Settings 11.12.3. Public Access Markets 11.12.4. Home Care Settings 11.12.5. Alternate Care Facilities 11.13. U.K. Defibrillators Market Forecast, By Product 11.13.1. Implantable Cardioverter Defibrillators (ICDs) 11.13.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 11.13.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 11.13.1.1.2. Dual-chamber ICDs 11.13.1.1.3. Single-chamber ICDs 11.13.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 11.13.2. External Defibrillators 11.13.2.1. Automated External Defibrillators (AEDs) 11.13.2.1.1. Semi-automated External Defibrillators 11.13.2.1.2. Fully Automated External Defibrillators 11.13.2.2. Manual External Defibrillators 11.13.2.3. Wearable Cardioverter Defibrillators (WCDs) 11.14. France Defibrillators Market Forecast, By End User 11.14.1. Hospitals, Clinics, and Cardiac Centers 11.14.2. Pre-Hospital Care Settings 11.14.3. Public Access Markets 11.14.4. Home Care Settings 11.14.5. Alternate Care Facilities 11.15. France Defibrillators Market Forecast, By Product 11.15.1. Implantable Cardioverter Defibrillators (ICDs) 11.15.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 11.15.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 11.15.1.1.2. Dual-chamber ICDs 11.15.1.1.3. Single-chamber ICDs 11.15.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 11.15.2. External Defibrillators 11.15.2.1. Automated External Defibrillators (AEDs) 11.15.2.1.1. Semi-automated External Defibrillators 11.15.2.1.2. Fully Automated External Defibrillators 11.15.2.2. Manual External Defibrillators 11.15.2.3. Wearable Cardioverter Defibrillators (WCDs) 11.16. Italy Defibrillators Market Forecast, By End User 11.16.1. Hospitals, Clinics, and Cardiac Centers 11.16.2. Pre-Hospital Care Settings 11.16.3. Public Access Markets 11.16.4. Home Care Settings 11.16.5. Alternate Care Facilities 11.17. Italy Defibrillators Market Forecast, By Product 11.17.1. Implantable Cardioverter Defibrillators (ICDs) 11.17.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 11.17.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 11.17.1.1.2. Dual-chamber ICDs 11.17.1.1.3. Single-chamber ICDs 11.17.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 11.17.2. External Defibrillators 11.17.2.1. Automated External Defibrillators (AEDs) 11.17.2.1.1. Semi-automated External Defibrillators 11.17.2.1.2. Fully Automated External Defibrillators 11.17.2.2. Manual External Defibrillators 11.17.2.3. Wearable Cardioverter Defibrillators (WCDs) 11.18. Spain Defibrillators Market Forecast, By End User 11.18.1. Hospitals, Clinics, and Cardiac Centers 11.18.2. Pre-Hospital Care Settings 11.18.3. Public Access Markets 11.18.4. Home Care Settings 11.18.5. Alternate Care Facilities 11.19. Spain Defibrillators Market Forecast, By Product 11.19.1. Implantable Cardioverter Defibrillators (ICDs) 11.19.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 11.19.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 11.19.1.1.2. Dual-chamber ICDs 11.19.1.1.3. Single-chamber ICDs 11.19.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 11.19.2. External Defibrillators 11.19.2.1. Automated External Defibrillators (AEDs) 11.19.2.1.1. Semi-automated External Defibrillators 11.19.2.1.2. Fully Automated External Defibrillators 11.19.2.2. Manual External Defibrillators 11.19.2.3. Wearable Cardioverter Defibrillators (WCDs) 11.20. Rest of Europe Defibrillators Market Forecast, By End User 11.20.1. Hospitals, Clinics, and Cardiac Centers 11.20.2. Pre-Hospital Care Settings 11.20.3. Public Access Markets 11.20.4. Home Care Settings 11.20.5. Alternate Care Facilities 11.21. Rest of Europe Defibrillators Market Forecast, By Product 11.21.1. Implantable Cardioverter Defibrillators (ICDs) 11.21.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 11.21.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 11.21.1.1.2. Dual-chamber ICDs 11.21.1.1.3. Single-chamber ICDs 11.21.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 11.21.2. External Defibrillators 11.21.2.1. Automated External Defibrillators (AEDs) 11.21.2.1.1. Semi-automated External Defibrillators 11.21.2.1.2. Fully Automated External Defibrillators 11.21.2.2. Manual External Defibrillators 11.21.2.3. Wearable Cardioverter Defibrillators (WCDs) 11.22. Europe Defibrillators Market Attractiveness Analysis 11.22.1. By End User 11.22.2. By Product 11.23. PEST Analysis 11.24. Key Trends 11.25. Key Development 12. Asia Pacific Defibrillators Market Analysis 12.1. Key Findings 12.2. Asia Pacific Defibrillators Market Overview 12.3. Asia Pacific Defibrillators Market Value Share Analysis, By End User 12.4. Asia Pacific Defibrillators Market Forecast, By End User 12.4.1. Hospitals, Clinics, and Cardiac Centers 12.4.2. Pre-Hospital Care Settings 12.4.3. Public Access Markets 12.4.4. Home Care Settings 12.4.5. Alternate Care Facilities 12.5. Asia Pacific Defibrillators Market Value Share Analysis, By Product 12.6. Asia Pacific Defibrillators Market Forecast, By Product 12.6.1. Implantable Cardioverter Defibrillators (ICDs) 12.6.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 12.6.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 12.6.1.1.2. Dual-chamber ICDs 12.6.1.1.3. Single-chamber ICDs 12.6.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 12.6.2. External Defibrillators 12.6.2.1. Automated External Defibrillators (AEDs) 12.6.2.1.1. Semi-automated External Defibrillators 12.6.2.1.2. Fully Automated External Defibrillators 12.6.2.2. Manual External Defibrillators 12.6.2.3. Wearable Cardioverter Defibrillators (WCDs) 12.7. Asia Pacific Defibrillators Market Value Share Analysis, By Country 12.8. Asia Pacific Defibrillators Market Forecast, By Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Defibrillators Market Analysis, By Country 12.10. China Defibrillators Market Forecast, By End User 12.10.1. Hospitals, Clinics, and Cardiac Centers 12.10.2. Pre-Hospital Care Settings 12.10.3. Public Access Markets 12.10.4. Home Care Settings 12.10.5. Alternate Care Facilities 12.11. China Defibrillators Market Forecast, By Product 12.11.1. Implantable Cardioverter Defibrillators (ICDs) 12.11.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 12.11.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 12.11.1.1.2. Dual-chamber ICDs 12.11.1.1.3. Single-chamber ICDs 12.11.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 12.11.2. External Defibrillators 12.11.2.1. Automated External Defibrillators (AEDs) 12.11.2.1.1. Semi-automated External Defibrillators 12.11.2.1.2. Fully Automated External Defibrillators 12.11.2.2. Manual External Defibrillators 12.11.2.3. Wearable Cardioverter Defibrillators (WCDs) 12.12. India Defibrillators Market Forecast, By End User 12.12.1. Hospitals, Clinics, and Cardiac Centers 12.12.2. Pre-Hospital Care Settings 12.12.3. Public Access Markets 12.12.4. Home Care Settings 12.12.5. Alternate Care Facilities 12.13. India Defibrillators Market Forecast, By Product 12.13.1. Implantable Cardioverter Defibrillators (ICDs) 12.13.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 12.13.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 12.13.1.1.2. Dual-chamber ICDs 12.13.1.1.3. Single-chamber ICDs 12.13.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 12.13.2. External Defibrillators 12.13.2.1. Automated External Defibrillators (AEDs) 12.13.2.1.1. Semi-automated External Defibrillators 12.13.2.1.2. Fully Automated External Defibrillators 12.13.2.2. Manual External Defibrillators 12.13.2.3. Wearable Cardioverter Defibrillators (WCDs) 12.14. Japan Defibrillators Market Forecast, By End User 12.14.1. Hospitals, Clinics, and Cardiac Centers 12.14.2. Pre-Hospital Care Settings 12.14.3. Public Access Markets 12.14.4. Home Care Settings 12.14.5. Alternate Care Facilities 12.15. Japan Defibrillators Market Forecast, By Product 12.15.1. Implantable Cardioverter Defibrillators (ICDs) 12.15.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 12.15.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 12.15.1.1.2. Dual-chamber ICDs 12.15.1.1.3. Single-chamber ICDs 12.15.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 12.15.2. External Defibrillators 12.15.2.1. Automated External Defibrillators (AEDs) 12.15.2.1.1. Semi-automated External Defibrillators 12.15.2.1.2. Fully Automated External Defibrillators 12.15.2.2. Manual External Defibrillators 12.15.2.3. Wearable Cardioverter Defibrillators (WCDs) 12.16. ASEAN Defibrillators Market Forecast, By End User 12.16.1. Hospitals, Clinics, and Cardiac Centers 12.16.2. Pre-Hospital Care Settings 12.16.3. Public Access Markets 12.16.4. Home Care Settings 12.16.5. Alternate Care Facilities 12.17. ASEAN Defibrillators Market Forecast, By Product 12.17.1. Implantable Cardioverter Defibrillators (ICDs) 12.17.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 12.17.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 12.17.1.1.2. Dual-chamber ICDs 12.17.1.1.3. Single-chamber ICDs 12.17.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 12.17.2. External Defibrillators 12.17.2.1. Automated External Defibrillators (AEDs) 12.17.2.1.1. Semi-automated External Defibrillators 12.17.2.1.2. Fully Automated External Defibrillators 12.17.2.2. Manual External Defibrillators 12.17.2.3. Wearable Cardioverter Defibrillators (WCDs) 12.18. Rest of Asia Pacific Defibrillators Market Forecast, By End User 12.18.1. Hospitals, Clinics, and Cardiac Centers 12.18.2. Pre-Hospital Care Settings 12.18.3. Public Access Markets 12.18.4. Home Care Settings 12.18.5. Alternate Care Facilities 12.19. Rest of Asia Pacific Defibrillators Market Forecast, By Product 12.19.1. Implantable Cardioverter Defibrillators (ICDs) 12.19.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 12.19.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 12.19.1.1.2. Dual-chamber ICDs 12.19.1.1.3. Single-chamber ICDs 12.19.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 12.19.2. External Defibrillators 12.19.2.1. Automated External Defibrillators (AEDs) 12.19.2.1.1. Semi-automated External Defibrillators 12.19.2.1.2. Fully Automated External Defibrillators 12.19.2.2. Manual External Defibrillators 12.19.2.3. Wearable Cardioverter Defibrillators (WCDs) 12.20. Asia Pacific Defibrillators Market Attractiveness Analysis 12.20.1. By End User 12.20.2. By Product 12.21. PEST Analysis 12.22. Key Trends 12.23. Key Development 13. Middle East & Africa Defibrillators Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Defibrillators Market Overview 13.3. Middle East & Africa Defibrillators Market Value Share Analysis, By End User 13.4. Middle East & Africa Defibrillators Market Forecast, By End User 13.4.1. Hospitals, Clinics, and Cardiac Centers 13.4.2. Pre-Hospital Care Settings 13.4.3. Public Access Markets 13.4.4. Home Care Settings 13.4.5. Alternate Care Facilities 13.5. Middle East & Africa Defibrillators Market Value Share Analysis, By Product 13.6. Middle East & Africa Defibrillators Market Forecast, By Product 13.6.1. Implantable Cardioverter Defibrillators (ICDs) 13.6.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 13.6.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 13.6.1.1.2. Dual-chamber ICDs 13.6.1.1.3. Single-chamber ICDs 13.6.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 13.6.2. External Defibrillators 13.6.2.1. Automated External Defibrillators (AEDs) 13.6.2.1.1. Semi-automated External Defibrillators 13.6.2.1.2. Fully Automated External Defibrillators 13.6.2.2. Manual External Defibrillators 13.6.2.3. Wearable Cardioverter Defibrillators (WCDs) 13.7. Middle East & Africa Defibrillators Market Value Share Analysis, By Country 13.8. Middle East & Africa Defibrillators Market Forecast, By Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Defibrillators Market Analysis, By Country 13.10. GCC Defibrillators Market Forecast, By End User 13.10.1. Hospitals, Clinics, and Cardiac Centers 13.10.2. Pre-Hospital Care Settings 13.10.3. Public Access Markets 13.10.4. Home Care Settings 13.10.5. Alternate Care Facilities 13.11. GCC Defibrillators Market Forecast, By Product 13.11.1. Implantable Cardioverter Defibrillators (ICDs) 13.11.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 13.11.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 13.11.1.1.2. Dual-chamber ICDs 13.11.1.1.3. Single-chamber ICDs 13.11.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 13.11.2. External Defibrillators 13.11.2.1. Automated External Defibrillators (AEDs) 13.11.2.1.1. Semi-automated External Defibrillators 13.11.2.1.2. Fully Automated External Defibrillators 13.11.2.2. Manual External Defibrillators 13.11.2.3. Wearable Cardioverter Defibrillators (WCDs) 13.12. South Africa Defibrillators Market Forecast, By End User 13.12.1. Hospitals, Clinics, and Cardiac Centers 13.12.2. Pre-Hospital Care Settings 13.12.3. Public Access Markets 13.12.4. Home Care Settings 13.12.5. Alternate Care Facilities 13.13. South Africa Defibrillators Market Forecast, By Product 13.13.1. Implantable Cardioverter Defibrillators (ICDs) 13.13.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 13.13.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 13.13.1.1.2. Dual-chamber ICDs 13.13.1.1.3. Single-chamber ICDs 13.13.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 13.13.2. External Defibrillators 13.13.2.1. Automated External Defibrillators (AEDs) 13.13.2.1.1. Semi-automated External Defibrillators 13.13.2.1.2. Fully Automated External Defibrillators 13.13.2.2. Manual External Defibrillators 13.13.2.3. Wearable Cardioverter Defibrillators (WCDs) 13.14. Rest of Middle East & Africa Defibrillators Market Forecast, By End User 13.14.1. Hospitals, Clinics, and Cardiac Centers 13.14.2. Pre-Hospital Care Settings 13.14.3. Public Access Markets 13.14.4. Home Care Settings 13.14.5. Alternate Care Facilities 13.15. Rest of Middle East & Africa Defibrillators Market Forecast, By Product 13.15.1. Implantable Cardioverter Defibrillators (ICDs) 13.15.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 13.15.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 13.15.1.1.2. Dual-chamber ICDs 13.15.1.1.3. Single-chamber ICDs 13.15.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 13.15.2. External Defibrillators 13.15.2.1. Automated External Defibrillators (AEDs) 13.15.2.1.1. Semi-automated External Defibrillators 13.15.2.1.2. Fully Automated External Defibrillators 13.15.2.2. Manual External Defibrillators 13.15.2.3. Wearable Cardioverter Defibrillators (WCDs) 13.16. Middle East & Africa Defibrillators Market Attractiveness Analysis 13.16.1. By End User 13.16.2. By Product 13.17. PEST Analysis 13.18. Key Trends 13.19. Key Development 14. South America Defibrillators Market Analysis 14.1. Key Findings 14.2. South America Defibrillators Market Overview 14.3. South America Defibrillators Market Value Share Analysis, By End User 14.4. South America Defibrillators Market Forecast, By End User 14.4.1. Hospitals, Clinics, and Cardiac Centers 14.4.2. Pre-Hospital Care Settings 14.4.3. Public Access Markets 14.4.4. Home Care Settings 14.4.5. Alternate Care Facilities 14.5. South America Defibrillators Market Value Share Analysis, By Product 14.6. South America Defibrillators Market Forecast, By Product 14.6.1. Implantable Cardioverter Defibrillators (ICDs) 14.6.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 14.6.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 14.6.1.1.2. Dual-chamber ICDs 14.6.1.1.3. Single-chamber ICDs 14.6.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 14.6.2. External Defibrillators 14.6.2.1. Automated External Defibrillators (AEDs) 14.6.2.1.1. Semi-automated External Defibrillators 14.6.2.1.2. Fully Automated External Defibrillators 14.6.2.2. Manual External Defibrillators 14.6.2.3. Wearable Cardioverter Defibrillators (WCDs) 14.7. South America Defibrillators Market Value Share Analysis, By Country 14.8. South America Defibrillators Market Forecast, By Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. South America Defibrillators Market Analysis, By Country 14.10. Brazil Defibrillators Market Forecast, By End User 14.10.1. Hospitals, Clinics, and Cardiac Centers 14.10.2. Pre-Hospital Care Settings 14.10.3. Public Access Markets 14.10.4. Home Care Settings 14.10.5. Alternate Care Facilities 14.11. Brazil Defibrillators Market Forecast, By Product 14.11.1. Implantable Cardioverter Defibrillators (ICDs) 14.11.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 14.11.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 14.11.1.1.2. Dual-chamber ICDs 14.11.1.1.3. Single-chamber ICDs 14.11.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 14.11.2. External Defibrillators 14.11.2.1. Automated External Defibrillators (AEDs) 14.11.2.1.1. Semi-automated External Defibrillators 14.11.2.1.2. Fully Automated External Defibrillators 14.11.2.2. Manual External Defibrillators 14.11.2.3. Wearable Cardioverter Defibrillators (WCDs) 14.12. Mexico Defibrillators Market Forecast, By End User 14.12.1. Hospitals, Clinics, and Cardiac Centers 14.12.2. Pre-Hospital Care Settings 14.12.3. Public Access Markets 14.12.4. Home Care Settings 14.12.5. Alternate Care Facilities 14.13. Mexico Defibrillators Market Forecast, By Product 14.13.1. Implantable Cardioverter Defibrillators (ICDs) 14.13.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 14.13.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 14.13.1.1.2. Dual-chamber ICDs 14.13.1.1.3. Single-chamber ICDs 14.13.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 14.13.2. External Defibrillators 14.13.2.1. Automated External Defibrillators (AEDs) 14.13.2.1.1. Semi-automated External Defibrillators 14.13.2.1.2. Fully Automated External Defibrillators 14.13.2.2. Manual External Defibrillators 14.13.2.3. Wearable Cardioverter Defibrillators (WCDs) 14.14. Rest of South America Defibrillators Market Forecast, By End User 14.14.1. Hospitals, Clinics, and Cardiac Centers 14.14.2. Pre-Hospital Care Settings 14.14.3. Public Access Markets 14.14.4. Home Care Settings 14.14.5. Alternate Care Facilities 14.15. Rest of South America Defibrillators Market Forecast, By Product 14.15.1. Implantable Cardioverter Defibrillators (ICDs) 14.15.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 14.15.1.1.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 14.15.1.1.2. Dual-chamber ICDs 14.15.1.1.3. Single-chamber ICDs 14.15.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) 14.15.2. External Defibrillators 14.15.2.1. Automated External Defibrillators (AEDs) 14.15.2.1.1. Semi-automated External Defibrillators 14.15.2.1.2. Fully Automated External Defibrillators 14.15.2.2. Manual External Defibrillators 14.15.2.3. Wearable Cardioverter Defibrillators (WCDs) 14.16. South America Defibrillators Market Attractiveness Analysis 14.16.1. By End User 14.16.2. By Product 14.17. PEST Analysis 14.18. Key Trends 14.19. Key Development 15. Company Profiles 15.1. Market Share Analysis, By Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players By price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A By Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Medtronic 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.2. St. Jude Medical 15.3.3. Boston Scientific 15.3.4. Philips 15.3.5. ZOLL Medical Corporation 15.3.6. BIOTRONIK 15.3.7. Cardiac Science Corporation 15.3.8. LivaNova PLC 15.3.9. Physio-Control, Inc. 15.3.10. Medtronic PLC 15.3.11. LivaNova PLC 15.3.12. Nihon Kohden Corporation. 15.3.13. Abbott 15.3.14. Physio-Control, Inc. 15.3.15. Koninklijke Philips N.V. 15.3.16. Nihon Kohden Corporation 15.3.17. Microport 15.3.18. CU Medical System Inc 15.3.19. Stryker 15.3.20. Asahi Kasei Corporation 16. Primary Key Insights

About This Report

Report ID 13018
Category Medical Devices
Published Date Aug2019
Updated Date oct 2020
Contact Us